Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Industry
Bank accounts
Was a VAT taxpayer from 2015-08-01 to 2021-08-02. Removed from VAT register
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
5 public aid cases recorded, with a total value of $2,533,811.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $152$152 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 2, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $152$152 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Aug 9, 2017 | Aid for research and development projects: industrial research | $2.0M$1,953,097 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The following are authorised to submit declarations concerning the company's property rights and obligations and to sign on behalf of the company: A) in the case of a multi-member management board: two members of the management board acting jointly, including the Vice-President of the Management Board, if appointed; B) in the case of a one-person management board: a member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Centrum Innowacji - Akcelerator Technologii Fundacja Uniwersytetu Łódzkiego | 208 | $2,809.29 | 50.6083% |
| 200 | $2,701.24 | 48.6618% | |
Others | 3 | $40.52 | 0.7299% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Marcin Bielówka (54)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Tomasz Stanisław Łysek (50) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Marcin Molo (53) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| Proteon PharmaceuticalsS.A. | $2,026,826.52 | proteonpharmaspolkaakcyjna.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| UveraS.A. | $155,384.29 | uvera.eu | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Passio Biomaterialssp. z o.o. | $0.00 | passio.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-23 | Business suspended | |
| 2025-07-22 | Business resumed | |
| 2023-07-21 | Business suspended | |
| 2023-07-19 | Business resumed | |
| 2021-01-01 | Business suspended |
FAQ
Last updated: 2026-07-15